Zaluron

Zaluron® XL are prolonged release quetiapine tablets that are available in 50mg, 150mg, 200mg, 300mg and 400mg. All five strengths come in packs of 60 and are indicated for the treatment of bipolar disorder and schizophrenia.

Cost Comparison Table

Product Strength PIP Code Pack Size Formulation Zaluron®XL Quetiapine XL (Category C)1 Legal Category Save
£		 Saving
%		 SPC PIL
Strength: 50mg PIP Code: 393-9691 Pack Size: 60 Formulation: Prolonged release tablets Zaluron®XL: £27.96 Quetiapine XL (Category C)1: £67.66 Legal Category: POM Save: £39.70 Saving: 58% Summary of Product Characteristics - SPC Patient Information Leaflet - PIL
Strength: 150mg PIP Code: 393-9709 Pack Size: 60 Formulation: Prolonged release tablets Zaluron®XL: £46.96 Quetiapine XL (Category C)1: £113.10 Legal Category: POM Save: £66.14 Saving: 58% Summary of Product Characteristics - SPC Patient Information Leaflet - PIL
Strength: 200mg PIP Code: 393-9717 Pack Size: 60 Formulation: Prolonged release tablets Zaluron®XL: £46.96 Quetiapine XL (Category C)1: £113.10 Legal Category: POM Save: £66.14 Saving: 58% Summary of Product Characteristics - SPC Patient Information Leaflet - PIL
Strength: 300mg PIP Code: 393-9725 Pack Size: 60 Formulation: Prolonged release tablets Zaluron®XL: £70.71 Quetiapine XL (Category C)1: £170.00 Legal Category: POM Save: £99.29 Saving: 58% Summary of Product Characteristics - SPC Patient Information Leaflet - PIL
Strength: 400mg PIP Code: 393-9733 Pack Size: 60 Formulation: Prolonged release tablets Zaluron®XL: £93.98 Quetiapine XL (Category C)1: £226.20 Legal Category: POM Save: £132.22 Saving: 58% Summary of Product Characteristics - SPC Patient Information Leaflet - PIL

Key Benefits

  • Up to 58% more cost-effective than prescribing generically1
  • Bioequivalent to Seroquel XL® so patients can be safely switched over2
  • All 5 strengths available – allowing brand continuity for patients
  • Convenient once daily dosage
  • Guaranteed no price increase before 2025
  • Exclusively available from Alliance Healthcare and Phoenix Healthcare

Medical Information and Adverse Events Reporting

Please note that Fontus Health cannot answer any questions about your medical condition or give any health advice. If you have any concerns about a personal medical condition, please consult a healthcare professional.

To report a suspected adverse event to one of our products or to discuss a specific product enquiry either:

Call: +44 (0) 121 661 4615 or Email: [email protected]

Information on adverse event reporting to the UK Health Authority can be found at yellowcard.mhra.gov.uk